<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 30 year old man with a history of <z:hpo ids='HP_0002076'>migraine</z:hpo> presented at the neurology outpatient clinic with hypesthesia of the left side of his body during a <z:hpo ids='HP_0002076'>migraine</z:hpo> attack, which was unusual for him </plain></SENT>
<SENT sid="1" pm="."><plain>His family history was positive for <z:e sem="disease" ids="C0039445" disease_type="Disease or Syndrome" abbrv="">Rendu-Osler-Weber syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>MRI and magnetic resonance angiography (MRA) of the brain showed multiple small <z:mpath ids='MPATH_124'>infarcts</z:mpath>, without vascular malformations </plain></SENT>
<SENT sid="3" pm="."><plain>CT angiography revealed an <z:hpo ids='HP_0004947'>arteriovenous fistula</z:hpo> in the lung </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0039445" disease_type="Disease or Syndrome" abbrv="">Rendu-Osler-Weber syndrome</z:e> (or hereditary haemorrhagic <z:hpo ids='HP_0001009'>telangiectasia</z:hpo>, HHT) is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> condition affecting the blood vessels </plain></SENT>
<SENT sid="5" pm="."><plain>It is estimated that about 60-80% of the patients with a <z:hpo ids='HP_0006548'>pulmonary arteriovenous malformation</z:hpo> (<z:mp ids='MP_0006093'>AVM</z:mp>) have HHT </plain></SENT>
<SENT sid="6" pm="."><plain>Neurological complications include <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> and brain <z:mpath ids='MPATH_612'>abscess</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>Also, there is a higher prevalence of <z:hpo ids='HP_0002076'>migraine</z:hpo> in patients with HHT, although the role that HHT plays in the pathogenesis of <z:hpo ids='HP_0002076'>migraine</z:hpo> is unclear </plain></SENT>
<SENT sid="8" pm="."><plain>The treatment of choice of pulmonary <z:mp ids='MP_0006093'>AVM</z:mp> is endovascular treatment, with a success rate of 75% in the long term </plain></SENT>
</text></document>